Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
Mallinckrodt
Baxter
Express Scripts
AstraZeneca

Last Updated: August 8, 2022

Investigational Drug Information for Poziotinib


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the drug development status for Poziotinib?

Poziotinib is an investigational drug.

There have been 21 clinical trials for Poziotinib. The most recent clinical trial was a Phase 2 trial, which was initiated on May 12th 2022.

The most common disease conditions in clinical trials are Carcinoma, Non-Small-Cell Lung, Breast Neoplasms, and Lung Neoplasms. The leading clinical trial sponsors are Spectrum Pharmaceuticals, Inc, Hanmi Pharmaceutical Company Limited, and National OncoVenture.

There are fifty US patents protecting this investigational drug and five hundred and seventy-six international patents.

Recent Clinical Trials for Poziotinib
TitleSponsorPhase
A Study of Poziotinib in Previously Treated Participants With Locally Advanced or Metastatic NSCLC Harboring HER2 Exon 20 MutationsSpectrum Pharmaceuticals, IncPhase 3
Poziotinib and Ramucirumab for the Treatment of EGFR Exon 20 Mutant Stage IV Non-small Cell Lung CancerM.D. Anderson Cancer CenterPhase 2
A Study to Evaluate the Effect of Multiple Doses of Itraconazole, Phenytoin, and Paroxetine on the Single-Dose Pharmacokinetics of Poziotinib in Healthy Adult ParticipantsSpectrum Pharmaceuticals, IncPhase 1

See all Poziotinib clinical trials

Clinical Trial Summary for Poziotinib

Top disease conditions for Poziotinib
Top clinical trial sponsors for Poziotinib

See all Poziotinib clinical trials

US Patents for Poziotinib

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Poziotinib See Plans and Pricing Compounds and methods for inhibiting vacuolar ATPase University of Southern California (Los Angeles, CA) See Plans and Pricing
Poziotinib See Plans and Pricing Gene fusions and gene variants associated with cancer LIFE TECHNOLOGIES CORPORATION (Carlsbad, CA) See Plans and Pricing
Poziotinib See Plans and Pricing Controlled release dosage form TRIASTEK, INC. (Nanjing, CN) See Plans and Pricing
Poziotinib See Plans and Pricing Crystalline forms of C.sub.21H.sub.22Cl.sub.2N.sub.4O.sub.2 Biomed Valley Discoveries, Inc. (Kansas City, MO) Vertex Pharmaceuticals Incorporated (Boston, MA) See Plans and Pricing
Poziotinib See Plans and Pricing In vitro model for a tumor microenvironment HemoShear, LLC (Charlottesville, VA) See Plans and Pricing
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Poziotinib

Drugname Country Document Number Estimated Expiration Related US Patent
Poziotinib Australia AU2014254394 2033-04-17 See Plans and Pricing
Poziotinib China CN105378110 2033-04-17 See Plans and Pricing
Poziotinib China CN106414768 2033-04-17 See Plans and Pricing
Poziotinib European Patent Office EP2986736 2033-04-17 See Plans and Pricing
Poziotinib European Patent Office EP3122901 2033-04-17 See Plans and Pricing
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
Mallinckrodt
Baxter
Express Scripts
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.